角蛋白在肿瘤诊断及预后中的应用

doi:10.3760/cma.j.cn371439-20200318-00036

摘要/Abstract

摘要：

角蛋白是上皮细胞的骨架蛋白,可参与调控肿瘤细胞的凋亡耐受、生长及迁移,与肿瘤发生密切相关。有的角蛋白在肿瘤患者血清中的水平升高或高表达于肿瘤组织中,在临床上被广泛用于肿瘤的诊断;有的角蛋白的表达与肿瘤患者预后呈负相关,可作为肿瘤预后标志物。进一步阐明角蛋白联合其他标志物检测对肿瘤诊断及预后判断的价值,将为角蛋白应用于临床肿瘤诊断与预后评估提供理论依据。

关键词: 肿瘤, 角蛋白质类, 致癌作用, 诊断, 预后

Abstract:

Keratins are cytoskeleton proteins, which are involved in apoptotic resistance, growth and migration of cancer cells. The levels of some keratins are elevated in the serum of patients with cancers, or highly expressed in cancer tissues, and they are widely used in the diagnosis of tumor in clinic. The expressions of some keratins are negatively correlated with the prognosis of patients with cancers, and can be used as prognostic markers. Further clarifying the diagnostic and prognostic value of keratins combined with other markers detection can provide theoretical basis for the application of keratins in diagnosis and prognostic assessment of cancers.

Key words: Neoplasms, Keratins, Carcinogenesis, Diagnosis, Prognosis

任梦, 高燕, 陈琪, 岳文涛. 角蛋白在肿瘤诊断及预后中的应用[J]. 国际肿瘤学杂志, 2020, 47(6): 360-363.

Ren Meng, Gao Yan, Chen Qi, Yue Wentao. Application of keratins in cancer diagnosis and prognosis[J]. Journal of International Oncology, 2020, 47(6): 360-363.

参考文献 38

[1]	Homberg M, Magin TM. Beyond expectations: novel insights into epidermal keratin function and regulation[J]. Int Rev Cell Mol Biol, 2014,311:265-306. DOI: 10.1016/B978-0-12-800179-0.00007-6. doi: 10.1016/B978-0-12-800179-0.00007-6 pmid: 24952920
[2]	Karsch S, Buchau F, Magin TM, et al. An intact keratin network is crucial for mechanical integrity and barrier function in keratinocyte cell sheets[J]. Cell Mol Life Sci, 2020. DOI: 10.1007/s00018-019-03424-7. doi: 10.1007/s00018-020-03582-z pmid: 32594191
[3]	Bozza WP, Zhang Y, Zhang B. Cytokeratin 8/18 protects breast cancer cell lines from TRAIL-induced apoptosis[J]. Oncotarget, 2018,9(33):23264-23273. DOI: 10.18632/oncotarget.25297. doi: 10.18632/oncotarget.25297 pmid: 29796187
[4]	Zhang N, Zhang R, Zou K, et al. Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth[J]. Cell Death Dis, 2017,8(7):e2961. DOI: 10.1038/cddis.2017.339. doi: 10.1038/cddis.2017.339 pmid: 28749462
[5]	Bilandzic M, Rainczuk A, Green E, et al. Keratin-14 (KRT14) positive leader cells mediate mesothelial clearance and invasion by ovarian cancer Cells[J]. Cancers (Basel) 2019, 11(9).pii: E1228. DOI: 10.3390/cancers11091228.
[6]	Attallah AM, El-Far M, Ibrahim AR, et al. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1[J]. Br J Biomed Sci, 2018,75(3):122-127. DOI: 10.1080/09674845.2018.1456309. doi: 10.1080/09674845.2018.1456309 pmid: 29734875
[7]	Nagel M, Schulz J, Maderer A, et al. Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial[J]. Tumour Biol, 2018,40(3):1010428318764007. DOI: 10.1177/1010428318764007. doi: 10.1177/1010428318764007 pmid: 29534639
[8]	Akita M, Ajiki T, Fukumoto T, et al. Keratin 19-expressing hepatocellular carcinoma and small-duct type intrahepatic cholangiocarci-noma show a similar postoperative clinical course but have distinct genetic features[J]. Histopathology, 2019,75(3):385-393. DOI: 10.1111/his.13884. doi: 10.1111/his.13884 pmid: 31017316
[9]	刘冰, 杨帅, 费锡斌, 等. GPC-3联合CK-19免疫组化检测在肝细胞癌诊断及鉴别诊断中的应用[J]. 医学信息, 2019,32(23):169-170. DOI: 10.3969/j.issn.1006-1959.2019.23.054.
[10]	孙孟春. 血清Cyfra21-1、CA125、CEA水平检测对食管癌诊断的意义分析[J]. 临床研究, 2020,28(4):3-4.
[11]	Song KS, Nimse SB, Warkad SD, et al. Quantification of CYFRA 21-1 and a CYFRA 21-1-anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer[J]. Chem Commun (Camb), 2019,55(68):10060-10063. DOI: 10.1039/c9cc03620b. doi: 10.1039/C9CC03620B
[12]	王玲, 申鸿. 癌胚抗原、糖类抗原、CA125、血管生成素、细胞角蛋白19片段及甲胎蛋白检测在肺癌诊断中的临床研究[J]. 陕西医学杂志, 2019, (8):1080-1084. DOI: 10.3969/j.issn.1000-7377.2019.08.034.
[13]	Kriegsmann K, Cremer M, Zgorzelski C, et al. Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer[J]. Pathology, 2019,51(3):240-245. DOI: 10.1016/j.pathol.2018.11.009. doi: 10.1016/j.pathol.2018.11.009 pmid: 30798982
[14]	朱栋麟, 沈荣明, 刘晓强, 等. CK7、CK18、CK5/6及P63在不同类型肺癌组织中的表达分析[J]. 中国实用医药, 2014,9(5):1-3.
[15]	Abdelrahman AE, Rashed HE, Abdelgawad M, et al. Prognostic impact of EGFR and cytokeratin5/6 immunohistochemical expression in triple-negative breast cancer[J]. Ann Diagn Pathol, 2017,28:43-53. DOI: 10.1016/j.anndiagpath.2017.01.009. doi: 10.1016/j.anndiagpath.2017.01.009 pmid: 28648939
[16]	Werner S, Keller L, Pantel K. Epithelial keratins: biology and implications as diagnostic markers for liquid biopsies[J]. Mol Aspects Med, 2020,72:100817. DOI: 10.1016/j.mam.2019.09.001. doi: 10.1016/j.mam.2019.09.001 pmid: 31563278
[17]	陈丽芬, 赵璐, 陈佳琦, 等. 血清糖类抗原153、糖类抗原125、细胞角蛋白19片段联合彩色多普勒高频超声检查在早期乳腺癌诊断中的价值[J]. 中国卫生检验杂志, 2020,30(2):215-218.
[18]	Kalfert D, Ludvik J, Kucera R, et al. Pretreatment serum levels of soluble cytokeratin fragments (Cyfra 21-1, TPS, MonoTotal) in relation to clinical and pathobiological aspects of head and neck squamous cell carcinomas[J]. Anticancer Res, 2019,39(9):5171-5177. DOI: 10.21873/anticanres.13713. doi: 10.21873/anticanres.13713 pmid: 31519630
[19]	Minciacchi VR, You S, Spinelli C, et al. Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles[J]. Oncotarget, 2015,6(13):11327-11341. DOI: 10.18632/oncotarget.3598. doi: 10.18632/oncotarget.3598 pmid: 25857301
[20]	Li YP, Jia XP, Jiang YQ, et al. Differential expression of cytokeratin 14 and 18 in bladder cancer tumorigenesis[J]. Exp Biol Med (Maywood), 2018,243(4):344-349. DOI: 10.1177/1535370218754493. doi: 10.1177/1535370218754493
[21]	Song XM, Wang ZJ, Cao WJ, et al. The value of circulating CYFRA21-1 expression in patients with nasopharyngeal carcinoma: a study of 529 subjects[J]. Int J Clin Oncol, 2016,21(6):1038-1045. DOI: 10.1007/s10147-016-1020-y. doi: 10.1007/s10147-016-1020-y pmid: 27405513
[22]	Jin C, Yang M, Han X, et al. Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125[J]. J Ovarian Res, 2019,12(1):114. DOI: 10.1186/s13048-019-0587-0. doi: 10.1186/s13048-019-0587-0 pmid: 31767040
[23]	Rao X, Wang J, Song HM, et al. KRT15 overexpression predicts poor prognosis in colorectal cancer[J]. Neoplasma, 2020,67(2):410-414. DOI: 10.4149/neo_2019_190531N475. doi: 10.4149/neo_2019_190531N475 pmid: 31884802
[24]	Zhang J, Hu S, Li Y, KRT18 is correlated with the malignant status and acts as an oncogene in colorectal cancer[J]. Biosci Rep, 2019, 39(8). pii: BSR20190884. DOI: 10.1042/BSR20190884. doi: 10.1042/BSR20190720 pmid: 31366565
[25]	Hung CS, Wang YC, Guo JW, et al. Expression pattern of placenta specific 8 and keratin 20 in different types of gastrointestinal cancer[J]. Mol Med Rep, 2020,21(2):659-666. DOI: 10.3892/mmr.2019.10871. doi: 10.3892/mmr.2019.10871 pmid: 31974611
[26]	Chen W, Zhang W, Wu R, et al. Identification of biomarkers associated with histological grade and prognosis of gastric cancer by co-expression network analysis[J]. Oncol Lett, 2019,18(5):5499-5507. DOI: 10.3892/ol.2019.10869. doi: 10.3892/ol.2019.10869 pmid: 31612058
[27]	Takashima K, Fujii S, Komatsuzaki R, et al. CD24 and CK4 are upregulated by SIM2, and are predictive biomarkers for chemoradiotherapy and surgery in esophageal cancer[J]. Int J Oncol, 2020,56(3):835-847. DOI: 10.3892/ijo.2020.4963. doi: 10.3892/ijo.2020.4963 pmid: 32124945
[28]	Karstens KF, Ghadban T, Effenberger K, et al. ymph node and bone marrow micrometastases define the prognosis of patients with pN0 esophageal cancer[J]. Cancers (Basel), 2020, 12(3). pii: E588. DOI: 10.3390/cancers12030588.
[29]	Xiao J, Kuang X, Dai L, et al. Anti-tumor effects of Keratin 6A in lung adenocarcinoma[J]. Clin Respir J, 2020. DOI: 10.1111/crj.13182. doi: 10.1111/crj.13214 pmid: 32421898
[30]	Hu HB, Yang XP, Zhou PX, et al. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma[J]. Genes Genomics, 2020,42(2):179-188. DOI: 10.1007/s13258-019-00889-5. doi: 10.1007/s13258-019-00889-5 pmid: 31768767
[31]	Wang Z, Yang MQ, Lei L, et al. Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis[J]. Cancer Manag Res, 2019,11:7485-7497. DOI: 10.2147/CMAR.S218926. doi: 10.2147/CMAR.S218926 pmid: 31496806
[32]	Shirasu H, Ono A, Omae K, et al. CYFRA 21-1 predicts the efficacy of nivolumab in patients with advanced lung adenocarcinoma[J]. Tumour Biol, 2018,40(2):1010428318760420. DOI: 10.1177/1010428318760420. doi: 10.1177/1010428318756203 pmid: 29421992
[33]	Robles AI, Ryan BM. KRT81 miR-SNP rs3660 is associated with risk and survival of NSCLC[J]. Ann Oncol, 2016,27(2):360-361. DOI: 10.1093/annonc/mdv552. doi: 10.1093/annonc/mdv552 pmid: 26578733
[34]	Zhao C, Lou Y, Wang Y, et al. A gene expression signature-based nomogram model in prediction of breast cancer bone metastases[J]. Cancer Med, 2019,8(1):200-208. DOI: 10.1002/cam4.1932. doi: 10.1002/cam4.1932 pmid: 30575323
[35]	Perone Y, Farrugia AJ, Rodriguez-Meira A, et al. SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERalpha breast cancer[J]. Nat Commun, 2019,10(1):2115. DOI: 10.1038/s41467-019-09676-y. doi: 10.1038/s41467-019-09676-y pmid: 31073170
[36]	Ricciardelli C, Lokman NA, Pyragius CE, et al. Keratin 5 over-expression is associated with serous ovarian cancer recurrence and chemotherapy resistance[J]. Oncotarget, 2017,8(11):17819-17832. DOI: 10.18632/oncotarget.14867. doi: 10.18632/oncotarget.14867 pmid: 28147318
[37]	Bai JDK, Babu S, Roa-Peña L, et al. Keratin 17 is a negative prognostic biomarker in high-grade endometrial carcinomas [J]. Hum Pathol, 2019,94:40-50. DOI: 10.1016/j.humpath.2019.09.005. doi: 10.1016/j.humpath.2019.09.005 pmid: 31655172
[38]	Roh V, Hiou-Feige A, Misetic V, et al. The transcription factor FOXM1 regulates the balance between proliferation and aberrant differentiation in head and neck squamous cell carcinoma[J]. J Pathol, 2020,250(1):107-119. DOI: 10.1002/path.5342. doi: 10.1002/path.5342 pmid: 31465124